Biomea Fusion, Inc. Common Stock (BMEA) is a publicly traded Healthcare sector company. As of November 10, 2026, BMEA trades at $0.59 with a market cap of $41.08M and a P/E ratio of -4.43. BMEA moved -1.18% today. Year to date, BMEA is -55.30%; over the trailing twelve months it is -56.28%. Its 52-week range spans $0.54 to $3.08. Analyst consensus is strong buy with an average price target of $6.25. Rallies surfaces BMEA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BMEA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.59 |
| Market Cap | $41.08M |
| P/E Ratio | -4.43 |
| EPS | $-0.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.08 |
| 52-Week Low | $0.54 |
| Volume | 8.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.62M |
| Net Income | $-32.54M |
| Gross Margin | 0.00% |
4 analysts cover BMEA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.25.